Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR) [NA]
The individualized lung tumor stereotactic ablative radiotherapy (iSABR) trial for non-small cell lung cancer has completed and posted resul…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC by CT Images and Pathological Factors
A completed clinical trial reports on integrating machine learning with CT imaging and pathological factors to prognosticate stage I non-sma…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC [Phase 2]
A Phase 2 trial evaluated the combination of eftilagimod alpha (IMP321) with pembrolizumab in patients with previously untreated unresectabl…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [NA]
This completed randomized, placebo-controlled study evaluated the safety and potential efficacy of MS-20 in combination with pembrolizumab f…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Dose Individualization of Pemetrexed - IMPROVE-I [Phase 4]
This report provides an update on the Phase 4 IMPROVE-I trial evaluating dose individualization of pemetrexed in non-small cell lung cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: A CR-UK Phase I Trial of LY3143921 [Phase 1]
Phase I trial update for LY3143921 sponsored by Cancer Research UK; the study is Active Not Recruiting and explores multiple cancer indicati…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing the bevacizumab biosimilar SB-8 to Avastin in adults with advanced non-squamous non-small cell lung cancer; results …
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 dose-escalation study of JAB-3068, an SHP2 inhibitor, in adults with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France
A completed clinical trial reports outcomes for patients with resectable non-small cell lung cancer who received neoadjuvant nivolumab in co…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. [Phase 1, Phase 2]
A Phase 1/2a clinical trial evaluating UV1 vaccination in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Liquid Biopsy for Early Non-small Lung Cancer Detection
A completed clinical trial evaluating a liquid biopsy approach for early detection of non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. [Phase 1]
A Phase I/Ib trial of NZV930 alone and in combination with PDR001 and/or NIR178 in patients with advanced malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) [Phase 1]
Phase 1 trial update evaluating how DZD9008 influences the pharmacokinetics of cocktail probe drugs reflecting CYP3A4, P-gp, BCRP, and OATP1…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) [Phase 3]
A Phase 3 randomized trial named GECP-SCAT evaluating customized adjuvant chemotherapy for non-small-cell lung cancer has completed. Results…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: MR-Linac Guided Adaptive FSRT for Brain Metastases From Non-small Cell Lung Cancer [Phase 2]
Completed Phase 2 trial evaluating MR-Linac guided adaptive FSRT for brain metastases in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation [Phase 1]
A Phase 1 trial evaluating the SHP2 inhibitor BBP-398 in combination with sotorasib in patients with advanced KRAS-G12C-mutant solid tumors …
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation [Phase 1]
Phase 1 trial of the SHP2 inhibitor BBP-398 in combination with nivolumab for advanced KRAS-mutant non-small cell lung cancer has been termi…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib [Phase 2]
Phase 2 clinical study of combination therapy ABSK043 and Firmonertinib is currently recruiting for non-small cell lung cancer with EGFR mut…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer
This clinical trial update describes a first-line study in metastatic non-small cell lung cancer evaluating nivolumab plus ipilimumab with t…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of ONO-4538 (nivolumab) in patients with advanced non-small cell lung cancer has completed. Results were posted on 2024-12-09.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
This completed clinical trial update examines how prevalent brain metastases are in lung cancer and assesses their impact on survival across…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating immunotherapy combinations in patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following Resection
A completed clinical study evaluating circulating tumor DNA (ctDNA) in patients with Non-Small Cell Lung Cancer following surgical resection…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 Inhibitor [Phase 2]
Phase 2 trial evaluating the combination of sintilimab and anlotinib in metastatic non-small cell lung cancer after a prior PD-1 inhibitor h…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLC
Real-world evidence evaluating long-term safety and efficacy of durvalumab after concurrent chemoradiation in patients with unresectable sta…